Search

Meeting Coverage:

American Society of Cataract and Refractive Surgery Meeting

ASCRS: 2025

Patient-Reported Outcomes in Reversing Pharmacologically Induced Mydriasis

Y. Ralph Chu, MD

Show Description +

Y. Ralph Chu, MD, recaps his talk from the ASCRS annual meeting in Los Angeles in which he presented on patient-reported outcomes data using phentolamine ophthalmic solution 0.75% for the reversal of mydriasis. He explains how the study showed improved symptoms within 1-2 hours of instillation, alleviating the negative symptoms of dilation such as blurred vision and glare.

Posted: 4/08/2025

Keywords:

Mydriasis

•

ASCRS

•

blurred vision

Up Next

Achieving Precise Toric IOL Alignment

Achieving Precise Toric IOL Alignment

Douglas Koch, MD

Big Data and AI in Glaucoma

Big Data and AI in Glaucoma

Robert Chang, MD

Prevalence and Risk Factors for Prolonged Postoperative Inflammation After Cataract Surgery

Prevalence and Risk Factors for Prolonged Postoperative Inflammation After Cataract Surgery

Rachel Schneider, MD

Comparison of Outcomes Following Implantation of Small Aperture or Trifocal IOL

Comparison of Outcomes Following Implantation of Small Aperture or Trifocal IOL

Lisa Feulner, MD, PhD

Cataract Surgery at Physiologic Intraocular Pressure

Cataract Surgery at Physiologic Intraocular Pressure

Matthew Rauen, MD

Imaging Update

Sanjay Asrani, MD

Intravitreal Drugs and the Glaucomas That Ensue

Intravitreal Drugs and the Glaucomas That Ensue

Lilian Nguyen, MD

Drug Delivery and the Quest for Control

Drug Delivery and the Quest for Control

Douglas Rhee, MD

Government Relations and Getting Involved

Government Relations and Getting Involved

Sue Hewitt, MD

Tips and Tricks for Direct SLT

Tips and Tricks for Direct SLT

Christine Funke, MD

$Assessing Refractive Astigmatism Outcomes With Toric IOL Alignment$

Assessing Refractive Astigmatism Outcomes With Toric IOL Alignment

Ben LaHood, MBChB, PGDipOphth, PhD, FRANZCO

Micro-Shockwave Therapy of the Sclera and Lens for Accommodation Restoration

Micro-Shockwave Therapy of the Sclera and Lens for Accommodation Restoration

Ronald R. Krueger, MD, MSE

Multidosing Mapped: Where States Stand on Medication Multidosing

Multidosing Mapped: Where States Stand on Medication Multidosing

Margaret A. Tharp, BSc

Digital Visualization in Ophthalmic Surgery

Digital Visualization in Ophthalmic Surgery

Robert Weinstock, MD

Real-World Evidence and Visual Outcomes of a Full Visual Range IOL

Real-World Evidence and Visual Outcomes of a Full Visual Range IOL

Priya Mathews, MD

Accelerated Epi-On Crosslinking With Localized Riboflavin and Oxygenation

Accelerated Epi-On Crosslinking With Localized Riboflavin and Oxygenation

Ali Nowrouzi, MD, FEBO, FRCS

$Refractive Stability and Visual Acuity of a Modular Shape-Changing IOL$

Refractive Stability and Visual Acuity of a Modular Shape-Changing IOL

Steven Dell, MD

Patient-Reported Outcomes in Reversing Pharmacologically Induced Mydriasis

Patient-Reported Outcomes in Reversing Pharmacologically Induced Mydriasis

Y. Ralph Chu, MD

Back to All Videos

Patient-Reported Outcomes in Reversing Pharmacologically Induced Mydriasis

Y. Ralph Chu, MD

Y. Ralph Chu, MD, recaps his talk from the ASCRS annual meeting in Los Angeles in which he presented on patient-reported outcomes data using phentolamine ophthalmic solution 0.75% for the reversal of mydriasis. He explains how the study showed improved symptoms within 1-2 hours of instillation, alleviating the negative symptoms of dilation such as blurred vision and glare.

Posted: 4/08/2025

Keywords:

Mydriasis

•

ASCRS

•

blurred vision

Please log in to leave a comment.

More From ASCRS: 2025 Coverage

Achieving Precise Toric IOL Alignment

Achieving Precise Toric IOL Alignment

Douglas Koch, MD

Big Data and AI in Glaucoma

Big Data and AI in Glaucoma

Robert Chang, MD

Prevalence and Risk Factors for Prolonged Postoperative Inflammation After Cataract Surgery

Prevalence and Risk Factors for Prolonged Postoperative Inflammation After Cataract Surgery

Rachel Schneider, MD

Comparison of Outcomes Following Implantation of Small Aperture or Trifocal IOL

Comparison of Outcomes Following Implantation of Small Aperture or Trifocal IOL

Lisa Feulner, MD, PhD

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASCRS: 2025.